Different toxicity of cetuximab and panitumumab in metastatic colorectal cancer treatment: A systematic review and meta-analysis
Oncology | Jan 27, 2018
Petrelli F, et al. - Despite the similar overall toxicity profile, cetuximab and panitumumab retain peculiar safety characteristics, that, researchers intended to investigate via this meta-analysis. They found that in terms of the rate of severe adverse events, cetuximab- and panitumumab-based chemotherapy had different toxicity profiles.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
